Resmed (RMD) Other Operating Expenses (2009 - 2026)

Resmed's Other Operating Expenses history runs 18 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• Quarterly Other Operating Expenses rose 3.23% year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.9 million (up 9.7% YoY) and the FY2023 annual result came in at $20.2 million, changed N/A from the prior year.
• Other Operating Expenses was $11.2 million for Q1 2026 at Resmed, down from $11.8 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $75.8 million in Q4 2023 and bottomed at $7.7 million in Q1 2022.
• A 5-year average of $15.5 million and a median of $11.3 million in 2024 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2023 — Other Operating Expenses jumped 692.69% — and 2024, when it tumbled 85.43%.
• Resmed's Other Operating Expenses stood at $9.6 million in 2022, then soared by 692.69% to $75.8 million in 2023, then tumbled by 85.43% to $11.0 million in 2024, then rose by 6.49% to $11.8 million in 2025, then slipped by 4.39% to $11.2 million in 2026.
• Business Quant data shows RMD's Other Operating Expenses at $11.2 million in Q1 2026, $11.8 million in Q4 2025, and $12.0 million in Q3 2025.